Moreover, a study by Andersson and colleagues showed that ErbB4 mRNA and protein expression was highest in low-grade gliomas, compared with higher grade tumors, suggesting that ErbB4 may act as a tumor suppressor (100). The gene discussed is ERBB4; the disease is central nervous system cancer.